SciELO - Scientific Electronic Library Online

 
vol.58 issue6Concordance between intraoperative frozen section and deferred biopsy for the diagnosis of malignant thyroid lesions author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Journal

Article

Indicators

Related links

Share


Revista chilena de cirugía

On-line version ISSN 0718-4026

Abstract

BURDILES P, PATRICIO et al. Use of antacids and acid-suppressors for gastro-esophageal peptic symptoms and body mass index in adult urban population. Rev Chil Cir [online]. 2006, vol.58, n.6, pp.402-409. ISSN 0718-4026.  http://dx.doi.org/10.4067/S0718-40262006000600003.

Background: Overweight and obesity are considered precipitating factors in the apparition of symptoms of gastroesophageal reflux disease. Besides antacids and acid-suppressors are highly effective in the palliation of such symptoms. Aim: to assess the prevalence of heartburn and epigastric burning pain, triggering factors, consumption of antacids or acid-suppressors, auto-medication and Body Mass Index (BMI) in adult population. Patients and Method: using a personal interview and physical examination, 433 adult subjects were assessed, excluding those with previously diagnosed gastro-esophageal reflux disease, history of upper gastro-intestinal surgery, and use of these medications due to other conditions. Results: symptoms in study were present in 60.1% (62.9% in women and 57.3% in men) being epigastric burning pain more frequent (35.6%) than heartburn (24.5%). Among symptomatic subjects 95% used medication on regular basis. Daily symptoms were referred by 23.5% of subjects and among them 64% use acid-suppressors. On the contrary subjects with sporadic symptoms recur mainly to antacids (65%-83%). Auto-medication was recognized by 78%-92% of people with sporadic symptoms and significantly less (48%) by people with daily symptoms. Emotional stress (35.1%-58.6%), alcohol intake (9%) and spicy food (5%) were mentioned as important triggering factors. Less than 4% of subjects considered increase in body weight as an important precipitating factor. BMI in asymptomatic group was: women 23.2 ±3.4 kg/m2; men 24.3 ±3.3 kg/m2. Figures in symptomatic group were 22.5 ±3,1 kg/m2 and 25 ±3.5 kg/m2 respectively. In the former, overweight was 25.4% and obesity 5.7% not significantly different than 28.5% y 10.4% respectively in symptomatic group. Conclusions: The vast majority of symptomatic subjects successfully use medication for palliation. Subjects with sporadic symptoms use mainly antacids while subjects with daily symptoms use mainly acid-suppressors. There is no association between frequency of peptic gastro-esophageal symptoms and BMI

Keywords : Peptic symptoms; antacids and acid-suppressors; body mass index.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )